USAID is most often covered alongside CDC, which appears in 1 of these 2 stories. That works out to roughly 0.1 stories per week across a 136-day span. The 7.5 average consequence score is above the beat benchmark of 6.2 in the same window.
Coverage balanceBalanced directional read. Positive and negative coverage are within 0 percentage points.
50% positive
50% negative
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about USAID
USAID is most often covered alongside CDC, which appears in 1 of these 2 stories. That works out to roughly 0.1 stories per week across a 136-day span. The 7.5 average consequence score is above the beat benchmark of 6.2 in the same window. Each story carries 4.5 original sources on average, compared with 3.5 for the broader beat in this window. funding accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. This profile follows 2 Biotech stories mentioning USAID across the period from February 27, 2026 to July 12, 2026.
Stories tracked
2
Per week
0.1
Sources per story
4.5
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 439 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering USAID. Shared-story counts are live from our verified record — not editorial picks.
For biopharma manufacturers, the restructuring of PEPFAR and the September award expirations threaten high-volume procurement contracts and stable antiretroviral demand. The cliff could disrupt clinical trial infrastructure, inventory planning, and generic drug production that have relied on predictable US funding for over two decades.
The United States and the Democratic Republic of the Congo have finalized a $1.2 billion health partnership aimed at strengthening healthcare infrastructure and disease surveillance. This multi-year commitment focuses on global health security, infectious disease control, and improving maternal and child health outcomes.
USAID is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.